{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:18:32Z","timestamp":1759331912414},"reference-count":32,"publisher":"Informa Healthcare","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2009,6,1]]},"DOI":"10.1185\/03007990902953286","type":"journal-article","created":{"date-parts":[[2009,5,20]],"date-time":"2009-05-20T11:31:33Z","timestamp":1242819093000},"page":"1535-1550","source":"Crossref","is-referenced-by-count":13,"title":["Postmarketing surveillance of serious adverse events associated with the use of rofecoxib from 1999\u20132002"],"prefix":"10.1185","volume":"25","author":[{"suffix":"Jr.","given":"Frank G.","family":"Bottone","sequence":"first","affiliation":[{"name":"Duke University, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William T.","family":"Barry","sequence":"additional","affiliation":[{"name":"Duke University, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2009,5,14]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.15.1200"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.9.824"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.3.293"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1345\/aph.10094"},{"issue":"2","key":"CIT0005","first-page":"117","volume":"59","author":"Dajani EZ","year":"2008","journal-title":"J Physiol Pharmacol"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011233432103"},{"key":"CIT0007","unstructured":"Merck and Company IWS, NJ, USA. Vioxx Product Insert, 2002."},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200108093450607"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1161\/hc4401.100078"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.68.11.963"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.8.954"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe058314"},{"issue":"6","key":"CIT0013","first-page":"S31","volume":"19","author":"FitzGerald GA","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050493"},{"issue":"6","key":"CIT0015","first-page":"11","volume":"38","author":"Merck withdraws Vioxx","year":"2004","journal-title":"FDA Consum"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.12.1363"},{"key":"CIT0017","doi-asserted-by":"crossref","unstructured":"Collaborative overview of randomised trials of antiplatelet therapy \u2013 I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 1994;308(6921):81-106.","DOI":"10.1136\/bmj.308.6921.81"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa071841"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2006.16.33"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2004.00550.x"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2000.112244"},{"key":"CIT0022","first-page":"102","volume-title":"Iatrogenic Diseases","author":"Weber J","year":"1986"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.13.1414"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.16.1752"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69666-9"},{"issue":"2","key":"CIT0026","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/clpt.2008.204","volume":"85","author":"Fosbol E","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.616219"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-3-200502010-00005"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.13.jrv60011"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e318157f72d"},{"key":"CIT0031","unstructured":"Merck and Company IWS, NJ, USA. Celebrex\u00ae Product Insert, 2008."},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200427070-00002"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/03007990902953286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T09:19:02Z","timestamp":1599297542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/03007990902953286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,14]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6,1]]}},"alternative-id":["10.1185\/03007990902953286"],"URL":"https:\/\/doi.org\/10.1185\/03007990902953286","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,14]]}}}